Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Other Proteins

Recombinant TMEV VP3 Protein, N-His (VK009032)

Recombinant TMEV VP3 Protein, N-His
Recombinant TMEV VP3 Protein, N-His
Price(USD): $
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

Overview
Catalog No.VK009032
Description
Recombinant TMEV VP3 Protein, N-His (VK009032) expressed in E. coli, spanning Ser415-Gln646. Purity: >90% by SDS-PAGE.
Highlights
  • His-Tagged — N-terminal 6×His tag for IMAC purification.
  • E. coli Expression — High-yield, cost-effective production.
  • High Purity — >90% purity verified by SDS-PAGE.
Expression systemE. coli
AccessionP13899
Protein lengthSer415-Gln646
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesTheiler's murine encephalomyelitis virus (TMEV)
Nature Recombinant
Target VP3
Endotoxin level Please contact with the lab for this information.
Purity >90%
Predicted molecular weight 27.67 kDa
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesGenome polyprotein, Leader protein, L, Capsid protein VP0, VP4-VP2, Capsid protein VP4, P1A, Virion protein 4, Capsid protein VP2, P1B, Virion protein 2, Capsid protein VP3, P1C, Virion protein 3, Capsid protein VP1, P1D, Virion protein 1, Protein 2A, P2A, Protein 2B, P2B, Protein 2C, P2C, EC:3.6.4.13, Protein 3A, P3A, VPg, P3B, Protein 3B, Protease 3C, P3C, EC:3.4.22.28, Picornain 3C, RNA-directed RNA polymerase, RdRp, EC:2.7.7.48, 3D polymerase, 3Dpol, Protein 3D, 3D
Background

Genome polyprotein (VP3) is a ~256 kDa protein. Forms a complex with host RAN and probably binds to exportins carrying activated MAPK in order to mediate the hyperphosphorylation of host Phe/Gly containing nuclear pore proteins (Nups) resulting in cessation of active nucleocytoplasmic transport (Probable). Proteins with NLS signals fail to import, cellular mRNAs fail to export, and some proteins small enough for diffusion are not retained anymore (efflux). The resulting inhibition of cellular protein synthesis serves to ensure maximal viral gene expression and to evade host immune response. The leader protein also inhibits host interferon regulatory factor 3 (IRF3) dimerization, thereby blocking the transcriptional activation of IFN genes. Binds to host RNase L thereby preventing its activation by 2'-5' oligoadenylates in order to counteract the antiviral interferon-inducible OAS/RNase L pathway.

1. Ricour, C. et al. (2009) The Journal of general virology 90, 177-86. PMID: 19088287
2. Sorgeloos, F. et al. (2013) PLoS pathogens 9, e1003474. PMID: 23825954
3. Drappier, M. et al. (2018) PLoS pathogens 14, e1006989. PMID: 29652922
Note For research use only.
Images
  • Recombinant TMEV VP3 Protein, N-His

    SDS-PAGE

    SDS-PAGE for Recombinant TMEV VP3 Protein, N-His

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list